Shifa Tameer-e-Millat University   Report issue

Academic/Hospital Phase 2
Founded: Islamabad Pakistan (2012)

Organization Overview

First Clinical Trial
2020
NCT04218786
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shifa College of Medicine, Shifa Tameer-e-Millat University | Shifa Tameer e milat University | Shifa Tameer-e-Millat University | Shifa tameer e millat university Islamabad | Shifa tameer-e-millat university Islamabad

Active Ingredients

Drugs in Phase 2 Trials (1)

colchicine (colbenemid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 2)

Ischemia (Phase 2)

Myocardial Infarction (Phase 2)

Myocardial Ischemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1